January 6, 2020
Deidre McCabe, Director, Office of Communications, 410-767-3536
Maureen Regan, Deputy
Director, Office of Communications, 410-767-8649
Maryland awarded federal
innovation funds to address impact of the opioid crisis on maternal and child health
Baltimore, MD – The Maryland Department of Health
(MDH) has launched the Maternal Opioid Misuse (MOM) model this month, using
funds from the Centers for Medicare and Medicaid Services (CMS). The MOM
initiative focuses on improving care for pregnant and postpartum Medicaid
participants who are diagnosed with opioid use disorder (OUD).
“The Maryland Department of Health remains committed to ending
the opioid crisis, and the MOM model is one very specific but critical approach,”
said MDH Secretary Robert R. Neall. “By targeting these resources and
continuing to align efforts — from the federal level to our local partners — we
will increase support for women and families in seeking treatment and finding
success in recovery.”
According to CMS, substance use is a leading cause of
maternal death. Because pregnant and postpartum women are more likely to be
receiving health care, MOM focuses on providing additional resources to women
with OUD during and after their pregnancies. The initiative strives to deliver
better care from maternity and primary care to behavioral health care and
substance use disorder treatment.
Maryland is one of 10 states to secure MOM funding. The
state will receive $3.6 million over the next five years to implement the
initiative, with the opportunity to receive an additional $1.5 million based on
performance targets. Maryland’s Medicaid program will work with CMS to develop
long-term coverage and payment strategies, while working with its HealthChoice
managed care organizations to improve care and service delivery to pregnant and
postpartum women with OUD.
“As we continue to combat the opioid crisis, this new
funding presents a unique opportunity to improve health outcomes for one of
Maryland’s most vulnerable populations,” said MDH Chief Operating Officer
Dennis Schrader. “This initiative will result in bringing better health care to
mothers and children at an especially critical time.”
The new funding is a timely and strategic complement to the
CDC’s Overdose Data to Action grant, which MDH’s Public Health Administration
received in September 2019. The three-year cooperative agreement enables the
state to leverage more timely overdose data to support increased intervention
and prevention capacities.
According to the American College of Obstetricians and
Gynecologists, pregnant and postpartum women who misuse substances are at high
risk for poor maternal outcomes, including preterm labor and delivery
complications. The problems are frequently made worse by malnourishment,
interpersonal violence and other health-related social needs.
"The social aspects of health care play an enormous role
in public health,” said Deputy Secretary for Public Health Fran Phillips.
“Medicaid’s MOM initiative aligns with Public Health’s community-based opioid
intervention and prevention efforts. Together, we have greater potential to
help more women with opioid use disorder and their infants get better care
across the state.”
For more information about the MOM model, visit https://innovation.cms.gov/initiatives/maternal-opioid-misuse-model/.
For more information about the Overdose Data to Action,
For more information about Maryland’s response to the opioid
crisis, visit https://beforeitstoolate.maryland.gov.
The Maryland Department of Health is dedicated to
protecting and improving the health and safety of all Marylanders through
disease prevention, access to care, quality management and community
Follow us on Twitter @MDHealthDept and
201 W. Preston Street, Baltimore, MD 21201-2399
(410) 767-6500 or 1-877-463-3464